"Home of Mass General Brigham system offices at Assembly Row. Please note, health care services are NOT provided at this location."

During the past decade, Mass General Brigham conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mass General Brigham" are "Alzheimer Disease" (1 trials), "Cervical Spinal Instability" (1 trials), "Degenerative Disc Disease" (1 trials), "Dementia" (1 trials) and "Total Knee Arthroplasty" (1 trials). Many other conditions were trialed in "Mass General Brigham" in a lesser frequency.

Most popular intervention types in "Mass General Brigham" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Care Ecosystem" (1 trials), "Dexamethasone 16mg" (1 trials), "Dexamethasone 4mg" (1 trials) and "Dexamethasone 8 Mg/mL Injectable Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mass General Brigham" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mass General Brigham". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Mass General Brigham, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mass General Brigham, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".